Timothy Pawlik, MD, MPH, PhD
The Ohio State University Wexner Medical Center has appointed a nationally recognized surgeon and liver cancer expert to lead its surgical and surgical oncology programs. Timothy Pawlik, MD, MPH, PhD, will be the Chair of the Medical Center’s Department of Surgery, as well as The Urban Meyer III and Shelley Meyer Chair for Cancer Research. His positions will be effective August 1.
Dr. Pawlik comes to Ohio State from Johns Hopkins Hospital Department of Surgery, where he was the John L. Cameron Professor in Alimentary Tract Diseases, Chief of the Division of Surgical Oncology, Program Director of the Surgical Oncology Fellowship, and Director of the Johns Hopkins Liver Tumor Center. He has been at Johns Hopkins since 2005 as Professor of Surgery and Oncology.
Dr. Pawlik’s primary clinical interests include alimentary tract surgery, with a special interest in hepatic, pancreatic, and biliary diseases. He is a member of the Johns Hopkins’ Miller-Coulson Academy of Clinical Excellence, in recognition of consummate clinical excellence in his field.
Other Activities
Dr. Pawlik has edited five surgical textbooks. He received an honorary fellowship in the Royal Australasian College of Surgeons, as well as honorary fellowship status in the Brazilian Society of Surgical Oncology. He is an associate editor for Annals of Surgical Oncology and the Journal of Gastrointestinal Surgery and is Deputy Editor for JAMA Surgery.
Dr. Pawlik has served on the executive councils of several premier national surgical associations and is the Immediate Past-President of the Association for Academic Surgery. He is a member of the Society of Surgical Oncology, the Americas Hepato-Pancreato-Biliary Association, the Society of Clinical Surgery, The Halsted Society, and the American Surgical Association.
Dr. Pawlik received his medical degree from Tufts University School of Medicine, where he also received his MPH. He completed surgical training at the University of Michigan Hospital and spent 2 years at Massachusetts General Hospital as a surgical oncology research fellow. He completed advanced training in surgical oncology at The University of Texas MD Anderson Cancer Center.
He completed a fellowship in medical ethics at the Harvard School of Public Health, as well as a Master in Theological Studies degree from Harvard Divinity School. In addition, he was a National Institutes of Health KL2 Clinical Scholar and received a PhD from the Johns Hopkins Bloomberg School of Public Health in clinical investigations. ■
